Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK. - Vlachaki I; Zinzi D; Falla E; Mantopoulos T; Guy H; Jandu J; Dodgson A (The European journal of health economics : HEPAC : health economics in prevention and care, 2022)